FDA Inspection 759793 — B.M.P. Bulk Medicines & Pharmaceuticals GmbH

B.M.P. Bulk Medicines & Pharmaceuticals GmbH — FEI 3002174993

The FDA completed an inspection of B.M.P. Bulk Medicines & Pharmaceuticals GmbH on November 16, 2011 in Norderstedt. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
November 16, 2011
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Norderstedt (Germany)

Citations

IDCFRDescription
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
197521 CFR 211.182Written records kept in individual logs
360321 CFR 211.160(b)Scientifically sound laboratory controls
363921 CFR 211.204Returned drug procedures in writing and followed
430321 CFR 211.67(b)Written procedures fail to include